Edition:
United Kingdom

CHF Solutions Inc (CHFS.OQ)

CHFS.OQ on NASDAQ Stock Exchange Capital Market

3.76USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$3.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
110,083
52-wk High
$360.00
52-wk Low
$2.87

Chart for

About

CHF Solutions, Inc., formerly Sunshine Heart, Inc., is a medical device company. The Company is focused on commercializing the Aquadex FlexFlow System. The Aquadex FlexFlow System (Aquadex) is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy.... (more)

Overall

Beta: 2.48
Market Cap(Mil.): $7.48
Shares Outstanding(Mil.): 12.52
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 168.71 16.44
EPS (TTM): -- -- --
ROI: -- 9.50 10.62
ROE: -- 14.87 14.20

BRIEF-CHF Solutions Enters Into International Distribution Agreement With Transmedic Pte Ltd

* CHF SOLUTIONS - ENTERS INTERNATIONAL DISTRIBUTION AGREEMENT WITH TRANSMEDIC PTE LTD TO MARKET & SUPPORT CO'S AQUADEX FLEXFLOW SYSTEM IN SINGAPORE-REGION Source text for Eikon: Further company coverage:

13 Dec 2017

BRIEF-Chiang Li Family Reports A 13.1 Percent Passive Stake In CHF Solutions

* CHIANG LI FAMILY REPORTS A 13.1 PERCENT PASSIVE STAKE IN CHF SOLUTIONS INC AS ON NOV 22 - SEC FILING Source: (http://bit.ly/2AFJcq6) Further company coverage:

08 Dec 2017

BRIEF-CHF SOLUTIONS REPORTS QTRLY LOSS PER SHARE ‍$4.55

* CHF SOLUTIONS, INC. ANNOUNCES 21% REVENUE GROWTH FOR ITS THIRD QUARTER, 2017 AND PROVIDES COMPANY UPDATE

31 Oct 2017

BRIEF-CHF Solutions files for offering of up to $8.0 mln of common stock

* CHF Solutions Inc files for offering of up to $8.0 million of common stock - SEC filing‍​ Source text : (http://bit.ly/2zyK7aG) Further company coverage:

18 Oct 2017

BRIEF-Trend Discovery reports 5.05 pct passive stake in CHF Solutions‍​

* Trend Discovery LP reports 5.05 percent passive stake in CHF Solutions as of Oct 12 - SEC filing‍​ Source text: (http://bit.ly/2gfbEt9) Further company coverage:

12 Oct 2017

BRIEF-CHF SOLUTIONS ANNOUNCES 1 FOR 20 REVERSE SPLIT RATIO

* ‍ANNOUNCED A 1-FOR-20 REVERSE SPLIT OF ITS COMMON STOCK, EFFECTIVE OCT 12 Source text for Eikon: Further company coverage:

12 Oct 2017

BRIEF-CHF Solutions Q2 loss per share $0.47

* CHF Solutions, Inc. announces 18 pct revenue growth for its second quarter and provides company update

08 Aug 2017

BRIEF-CHF Solutions commences manufacturing transition of aquadex flexflow system to its minnesota facility

* has begun process of transitioning manufacturing of aquadex flexflow system from unit of Baxter International to co's facility in minnesota Source text for Eikon: Further company coverage:

03 Aug 2017

BRIEF-CHF's Aquadex Flexflow aquapheresis system receives FDA IDE approval for clinical study for pediatric use

* CHF Solutions’ aquadex flexflow® aquapheresis system receives FDA IDE approval for clinical study for pediatric use Source text for Eikon: Further company coverage:

29 Jun 2017

Competitors

Earnings vs. Estimates